Jeffrey P. Knittel, located in Parkville, MO, is a distinguished inventor with a notable portfolio comprising 10 patents. His work primarily revolves around the development of vaccines and methods aimed at combating infectious diseases in livestock, particularly ruminants. Through his innovative contributions, he has significantly impacted veterinary medicine and animal health.

Latest Patents

Among his latest innovations is a patent for the Schmallenberg virus (SBV) vaccine. This invention focuses on the prophylaxis and treatment of infectious diseases in ruminants, primarily targeting the prevention of viremia and clinical symptoms, including malformations in newborns such as cattle, sheep, and goats induced by the SBV. Additionally, another recent patent relates to immunological compositions of outer membrane proteins (OMPs), enhancing methods of extraction, administration, and diagnostic assays.

Career Highlights

Throughout his career, Jeffrey Knittel has held notable positions at reputable companies such as Boehringer Ingelheim Vetmedica GmbH and Nobl Laboratories, Inc. His work within these organizations has allowed him to collaborate on groundbreaking research and innovations in veterinary vaccines, underscoring his commitment to improving animal health.

Collaborations

Jeffrey has worked alongside accomplished colleagues, including Michael B. Roof and Michael Beck. These collaborations have been pivotal in advancing his research and the development of effective vaccines and therapeutic solutions.

Conclusion

Jeffrey P. Knittel’s innovations in veterinary vaccines showcase his dedication to enhancing the health and welfare of ruminants. With his extensive patent portfolio and collaborative efforts, he continues to be an influential figure in the field, contributing to the fight against infectious diseases in animals.

This text is generated by artificial intelligence and may not be accurate.